Sequenom, Inc. Announces Participation At The 33rd Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Jan. 6, 2015 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a leading molecular diagnostics company, today announced the Company's participation at the 2015 J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel, in San Francisco, CA on January 12-15, 2015.

William Welch, Chief Executive Officer, and Carolyn Beaver, Chief Financial Officer, will present on Thursday, January 15 at 8:00 a.m. PT to provide an overview of and update on the Company. The presentation is expected to last approximately 30 minutes and will be webcast live through the "Invest" section of the Sequenom Web site at www.sequenom.com. An audio replay will be available for 30 days following the initial broadcast. 

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is committed to enabling healthier lives through the development of innovative products and services.  The company serves patients and physicians by providing early patient management information.  To learn how Sequenom is interpreting the genome to improve your life, visit www.sequenom.com and follow @SequenomLabs.

Logo - http://photos.prnewswire.com/prnh/20040415/SQNMLOGO

SOURCE Sequenom, Inc.

Related Links

http://www.sequenom.com